Curanex Pharmaceuticals Inc Common Stock (CURX) — Cash Flow Reinvestment Rate
Curanex Pharmaceuticals Inc Common Stock (CURX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $3.34K. See CURX net asset quality index to measure how much of total assets are equity-financed.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Curanex Pharmaceuticals Inc Common Stock Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Curanex Pharmaceuticals Inc Common Stock across 1 annual periods. Also explore Curanex Pharmaceuticals Inc Common Stock asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Curanex Pharmaceuticals Inc Common Stock (2022–2022)
Year-by-year capital reinvestment analysis for Curanex Pharmaceuticals Inc Common Stock. For live market cap and broader valuation context, see market value of Curanex Pharmaceuticals Inc Common Stock.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.00x | $0.00 | $3.34K | $0.00 | — |